Caxton Associates LP bought a new stake in Express Scripts Holding Company (NASDAQ:ESRX) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 7,100 shares of the company’s stock, valued at approximately $468,000.

A number of other hedge funds also recently added to or reduced their stakes in ESRX. Dubuque Bank & Trust Co. increased its stake in Express Scripts Holding by 53.1% in the first quarter. Dubuque Bank & Trust Co. now owns 1,753 shares of the company’s stock valued at $116,000 after buying an additional 608 shares in the last quarter. TrimTabs Asset Management LLC bought a new stake in Express Scripts Holding during the first quarter valued at $121,000. Capital Analysts LLC increased its stake in Express Scripts Holding by 5.6% in the first quarter. Capital Analysts LLC now owns 1,877 shares of the company’s stock valued at $124,000 after buying an additional 100 shares in the last quarter. Pinnacle Bank bought a new stake in Express Scripts Holding during the first quarter valued at $143,000. Finally, Oakworth Capital Inc. increased its stake in Express Scripts Holding by 7.0% in the first quarter. Oakworth Capital Inc. now owns 2,362 shares of the company’s stock valued at $155,000 after buying an additional 155 shares in the last quarter. 90.20% of the stock is currently owned by institutional investors.

Express Scripts Holding Company (NASDAQ:ESRX) traded down 1.14% during trading on Thursday, reaching $60.50. 1,196,281 shares of the company’s stock were exchanged. Express Scripts Holding Company has a 52 week low of $57.80 and a 52 week high of $77.61. The firm has a market capitalization of $34.94 billion, a price-to-earnings ratio of 10.50 and a beta of 0.90. The stock has a 50-day moving average price of $62.96 and a 200 day moving average price of $64.58.

Express Scripts Holding (NASDAQ:ESRX) last issued its earnings results on Tuesday, July 25th. The company reported $1.73 EPS for the quarter, topping the consensus estimate of $1.71 by $0.02. The company had revenue of $25.35 billion for the quarter, compared to analyst estimates of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The business’s revenue was up .5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.57 EPS. Equities research analysts forecast that Express Scripts Holding Company will post $6.99 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This story was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this story on another site, it was stolen and republished in violation of U.S. & international copyright legislation. The legal version of this story can be read at https://www.dailypolitical.com/2017/08/10/caxton-associates-lp-invests-468000-in-express-scripts-holding-company-esrx.html.

ESRX has been the topic of several research analyst reports. SunTrust Banks, Inc. reissued a “buy” rating on shares of Express Scripts Holding in a research report on Tuesday, April 25th. Jefferies Group LLC set a $88.00 target price on shares of Express Scripts Holding and gave the stock a “buy” rating in a research report on Thursday, April 20th. UBS AG set a $71.00 target price on shares of Express Scripts Holding and gave the stock a “hold” rating in a research report on Tuesday, April 25th. Edward Jones downgraded shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a report on Wednesday, April 26th. Finally, BidaskClub raised shares of Express Scripts Holding from a “sell” rating to a “hold” rating in a report on Saturday, June 17th. Four research analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $70.81.

In other news, VP Phyllis S. Anderson sold 1,100 shares of Express Scripts Holding stock in a transaction on Friday, May 19th. The stock was sold at an average price of $60.08, for a total transaction of $66,088.00. Following the completion of the transaction, the vice president now owns 11,108 shares of the company’s stock, valued at approximately $667,368.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.68% of the company’s stock.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.